KEYTRUDA
NDC 0006-3026, pembrolizumab, injection, solution, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-3026
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125514
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEMBROLIZUMAB25 mg/mL
Pharmacologic classes
Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-3026-02 | 00006302602 | 1 VIAL in 1 CARTON (0006-3026-02) / 4 mL in 1 VIAL (0006-3026-01) |
| 0006-3026-04 | 00006302604 | 2 VIAL in 1 CARTON (0006-3026-04) / 4 mL in 1 VIAL (0006-3026-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9333c79b-d487-4538-a9f0-71b91a02b287Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0006-3026
Use it
Look up 0006-3026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-3026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.